Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers
type: MedicalStudy
description: A Multi-Center, Randomized, Double-Masked, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety of R89674 0.25% Ophthalmic Solution in Healthy, Normal Volunteers
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2005-09
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00223951
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Vistakon Pharmaceuticals
study subject: Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

AI Analytics
type: Organization